Multifunctional Asymmetric Bacterial Cellulose Membrane with Enhanced Anti‐Bacterial and Anti‐Inflammatory Activities for Promoting Infected Wound Healing
Source abstract
Abstract
Abstract An asymmetric wound dressing acts as a skin‐like structure serves as a protective barrier between a wound and its surroundings. It allows for the absorption of tissue fluids and the release of active substances at the wound site, thus speeding up the healing process. However, the production of such wound dressings requires the acquisition of specialized tools, expensive polymers, and solvents that contain harmful byproducts. In this study, an asymmetric bacterial cellulose (ABC) wound dressing using starch as a porogen has been developed. By incorporating silver‐metal organic frameworks (Ag‐MOF) and curcumin into the ABC membrane, the wound dressing gains antioxidant, reactive oxygen species (ROS) scavenging, and anti‐bacterial activities. Compared to BC‐based wound dressings, this dressing promotes efficient dissolution and controlled release of curcumin and silver ions. In a full‐thickness skin defect model, wound dressing not only inhibits the growth of bacteria on infected wounds but also regulates the release of curcumin to reduce inflammation and promote the production of epithelium, blood vessels, and collagen. Consequently, this dressing provides superior wound treatment compared to BC‐based dressing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Advanced Cellulose Research Studies · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Food Nutrition & Safety Tianjin University of Science and Technology Tianjin P. R. China
Key Laboratory of Industrial Fermentation Microbiology (Ministry of Education) Tianjin University of Science and Technology Tianjin P. R. China
College of Traditional Chinese Medicine Weifang Medical University Weifang Shandong P. R. China
Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants Tianjin P. R. China
Funding
National Natural Science Foundation of China
References (48)
Show source-provided references
1. 10.1155/2020/494690210.1155/2020/4946902 ↗
2. 10.1016/j.tibtech.2012.08.00410.1016/j.tibtech.2012.08.004 ↗
3. 10.1016/j.trsl.2018.10.00110.1016/j.trsl.2018.10.001 ↗
4. 10.1021/acsnano.1c0841110.1021/acsnano.1c08411 ↗
5. 10.1016/j.memsci.2015.04.06410.1016/j.memsci.2015.04.064 ↗
6. 10.1016/j.biomaterials.2014.10.07710.1016/j.biomaterials.2014.10.077 ↗
7. 10.1021/acsami.6b0471110.1021/acsami.6b04711 ↗
8. 10.1016/j.msec.2022.11266710.1016/j.msec.2022.112667 ↗
9. 10.1002/app.3281310.1002/app.32813 ↗
10. 10.1002/jbm.126010.1002/jbm.1260 ↗
11. 10.1016/j.memsci.2006.06.03710.1016/j.memsci.2006.06.037 ↗
12. 10.1080/15583724.2014.88137410.1080/15583724.2014.881374 ↗
13. 10.1002/bit.2445510.1002/bit.24455 ↗
14. 10.1016/j.ijbiomac.2019.01.07210.1016/j.ijbiomac.2019.01.072 ↗
15. 10.1021/acs.biomac.7b0166010.1021/acs.biomac.7b01660 ↗
16. 10.1016/j.msec.2021.11259110.1016/j.msec.2021.112591 ↗
17. 10.1021/acsami.7b1668010.1021/acsami.7b16680 ↗
18. 10.1016/j.ijbiomac.2021.11.19810.1016/j.ijbiomac.2021.11.198 ↗
19. 10.1039/C4CC03001J10.1039/C4CC03001J ↗
20. 10.2147/IJN.S16512510.2147/IJN.S165125 ↗
21. 10.1021/nn800596w10.1021/nn800596w ↗
22. 10.1021/mp700113r10.1021/mp700113r ↗
23. 10.1038/s41563-018-0104-710.1038/s41563-018-0104-7 ↗
24. 10.1016/j.foodhyd.2008.02.00310.1016/j.foodhyd.2008.02.003 ↗
25. 10.1021/bm501680s10.1021/bm501680s ↗
26. 10.1088/1748-605X/aa948610.1088/1748-605X/aa9486 ↗
27. 10.1016/j.carbpol.2011.12.02210.1016/j.carbpol.2011.12.022 ↗
28. 10.1021/acs.biomac.2c0017810.1021/acs.biomac.2c00178 ↗
29. 10.1016/j.cej.2021.13021910.1016/j.cej.2021.130219 ↗
30. 10.3389/fbioe.2020.55303710.3389/fbioe.2020.553037 ↗
31. 10.1016/j.memsci.2018.12.01610.1016/j.memsci.2018.12.016 ↗
32. 10.1002/smll.20190106510.1002/smll.201901065 ↗
33. 10.1021/acsami.6b0221810.1021/acsami.6b02218 ↗
34. 10.1039/c2cp40208d10.1039/c2cp40208d ↗
35. 10.1515/mgmc-2013-002310.1515/mgmc-2013-0023 ↗
36. 10.3390/nano1101022210.3390/nano11010222 ↗
37. 10.1016/j.btre.2017.07.00210.1016/j.btre.2017.07.002 ↗
38. 10.1016/j.cej.2016.04.08710.1016/j.cej.2016.04.087 ↗
39. 10.1016/S0142-9612(03)00625-210.1016/S0142-9612(03)00625-2 ↗
40. 10.1016/j.jinorgbio.2014.05.00510.1016/j.jinorgbio.2014.05.005 ↗
41. 10.1186/s12951-021-00863-y10.1186/s12951-021-00863-y ↗
42. 10.1002/adhm.20220323310.1002/adhm.202203233 ↗
43. 10.1021/acsami.8b0260210.1021/acsami.8b02602 ↗
44. 10.1016/j.carbpol.2023.12071810.1016/j.carbpol.2023.120718 ↗
45. 10.1016/j.carbpol.2019.11530210.1016/j.carbpol.2019.115302 ↗
46. 10.1016/j.msec.2021.11234210.1016/j.msec.2021.112342 ↗
47. 10.1016/j.cej.2020.12754210.1016/j.cej.2020.127542 ↗
48. 10.1016/j.colsurfb.2020.11109910.1016/j.colsurfb.2020.111099 ↗